SARS‐CoV‐2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease

BACKGROUND/AIMS: In this observational study, we explored the humoral and cellular immune response to SARS‐CoV‐2 vaccination in patients with autoimmune hepatitis (AIH) and patients with cholestatic autoimmune liver disease (primary sclerosing cholangitis [PSC] and primary biliary cholangitis [PBC])...

Descripción completa

Detalles Bibliográficos
Autores principales: Duengelhoef, Paul, Hartl, Johannes, Rüther, Darius, Steinmann, Silja, Brehm, Thomas T., Weltzsch, Jan Philipp, Glaser, Fabian, Schaub, G. M., Sterneck, Martina, Sebode, Marcial, Weiler‐Normann, Christina, Addo, Marylyn M., Lütgehetmann, Marc, Haag, Friedrich, Schramm, Christoph, Schulze zur Wiesch, Julian, Lohse, Ansgar W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Hepatobiliary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004241/
https://www.ncbi.nlm.nih.gov/pubmed/35289983
http://dx.doi.org/10.1002/ueg2.12218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004241/
https://www.ncbi.nlm.nih.gov/pubmed/35289983
http://dx.doi.org/10.1002/ueg2.12218

Ejemplares similares